ipilimumab,nivolumab,sintilimab,camrelizumab,toripalimab
innovent biologics,jiangsu hengrui pharmaceuticals,bms,Shanghai Junshi Bioscience
['check,mate,002', 'c,144,01', 'esophageal', 'orien', 'escort-1', 'orient-15', 'c,144,i', 'check,mate,004', 'check,mate,648']
 is there a benefit from anti-pd1 in pl-1 low esophageal squamous cell carcinoma? jupiter-06 phs iii &amp; meta-analysis of 5 rcts orr, pfs &amp; os benefit for tps &lt; 1% &amp; cps &lt;10, but mainly in asian pts 
Physician-scientist, focused on translational research in hepatobiliary cancer and precision medicine